Direct in vivo transfection of antisense Fas-ligand reduces tumor growth and invasion

Gene Therapy
J K NyhusE Barbera-Guillem

Abstract

The expression of Fas ligand (FasL) by tumor cells has been reported to have multiple, conflicting effects on tumor growth. The majority of the data support the theory that FasL expressing tumor cells evade immune surveillance by killing T cells expressing Fas. However, the role of the humoral immune-blockade by FasL expressing tumor cells has not been assessed. Using immune-competent mice, we observed that FasL expressing tumor cells reduced the antitumor antibody production together with the T and B cell content of the spleen in these mice. Further, to determine if the expression of FasL in the environment of the tumor suppresses the humoral antitumor immune response and influences tumor growth, a mouse model lacking T cells was used. To assess whether a local reduction of FasL could reduce tumor progression, a plasmid encoding antisense FasL cDNA was delivered directly into a growing tumor (SW620 colon carcinoma). Intratumoral delivery of the plasmid was able to transfect tumor cells, stromal cells, and peritumoral muscle cells. This antisense FasL tumor tissue transfection persisted for at least 25 days, produced a systemic decrease in soluble FasL, and resulted in a 50% reduction in the rate of tumor growth when compared w...Continue Reading

References

Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·D AshanyK B Elkon
Nov 1, 1995·European Journal of Immunology·L MandikJ Erikson
Nov 17, 1995·Science·T S GriffithT A Ferguson
Jan 1, 1995·The Journal of Experimental Medicine·M R AldersonD H Lynch
Aug 1, 1995·European Journal of Immunology·A Rensing-EhlA Fontana
Nov 1, 1995·The Journal of Experimental Medicine·P GarroneJ Banchereau
Sep 1, 1996·The Journal of Experimental Medicine·J O'ConnellF Shanahan
Dec 31, 1997·Science·S M KangH M Blau
Nov 14, 1998·Annals of Medicine·S M JaneE F Vanin
May 18, 1999·International Journal of Cancer. Journal International Du Cancer·L Peduto EberlL Juillerat-Jeanneret
Aug 13, 1999·Breast Cancer Research and Treatment·L S GutierrezG Mor

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.